Sales of Hospital Acquired Infection Treatment Market is Set to Increase at Under 2.5% CAGR by 2027

Hospital-acquired infections (HAIs), also known as nosocomial infections, are infections that patients acquire during their stay in healthcare facilities. These infections pose a significant burden on healthcare systems worldwide, leading to increased morbidity, mortality, and healthcare costs. The global Hospital Acquired Infection Treatment Market was valued at US$ 31.0 Bn in 2018 and is projected to reach US$ 38.8 Bn by 2027 by 2027, growing at a CAGR of 2.5% during the forecast period.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 (𝐔𝐬𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐌𝐚𝐢𝐥 𝐈𝐝 𝐟𝐨𝐫 𝐐𝐮𝐢𝐜𝐤 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞) - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17267&utm_source=OpenPR_Sudha&utm_campaign=OpenPR

The Hospital Acquired Infection Treatment Market is driven by the increasing prevalence of HAIs, the rise in geriatric population, and the growing awareness about infection control measures. The market is also fueled by advancements in healthcare infrastructure and the development of novel treatment options.

Market Size and Growth:

The market size for hospital-acquired infection treatment was valued at US$ 31.0 Bn in 2018 and is expected to grow at a CAGR of 2.5% during the forecast period from 2019 to 2027.

Market Segmentation:

By Service Type: Diagnostic, Therapeutic
By Sourcing Type: In-house, Outsourced
By Application: Urinary Tract Infections, Surgical Site Infections, Bloodstream Infections, Others
By Industry Vertical: Hospitals, Ambulatory Surgical Centers, Nursing Homes, Others
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Regional Analysis:

North America dominates the Hospital Acquired Infection Treatment Market due to the high prevalence of HAIs and the presence of well-established healthcare infrastructure. Europe follows closely, driven by government initiatives to control HAIs. The Asia Pacific region is expected to witness significant growth during the forecast period, attributed to the increasing healthcare expenditure and rising awareness about infection control.

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=17267&utm_source=OpenPR_Sudha&utm_campaign=OpenPR

Market Drivers and Challenges:

Drivers: Increasing prevalence of HAIs, rise in geriatric population, growing awareness about infection control measures
Challenges: High cost of treatment, antibiotic resistance, lack of skilled healthcare professionals

Market Trends:

Increasing use of advanced disinfection technologies
Rising adoption of antimicrobial stewardship programs
Development of novel treatment options

Competitive Landscape:

Key players in the Hospital Acquired Infection Treatment Market include companies such as Abbott Laboratories, Pfizer, Inc., Bayer AG, AstraZeneca, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Cipla Inc., and others. These companies are focusing on research and development activities to introduce new and effective treatment options.

𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲? 𝐀𝐬𝐤 𝐓𝐨 𝐀𝐧𝐚𝐥𝐲𝐬𝐭: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=17267&utm_source=OpenPR_Sudha&utm_campaign=OpenPR

Future Outlook:

The Hospital Acquired Infection Treatment Market is expected to witness significant growth in the coming years, driven by the increasing prevalence of HAIs and the growing demand for effective treatment options. However, challenges such as antibiotic resistance and the high cost of treatment are likely to hinder market growth.

Key Market Study Points:

Market size and growth rate
Market segmentation
Regional analysis
Market drivers and challenges
Market trends
Competitive landscape
Future outlook

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 -

Pharmacovigilance Market -https://www.globenewswire.com/news-release/2023/04/26/2655580/0/en/Pharmacovigilance-Market-to-Exhibit-USD-11-5-Bn-by-2028-Expanding-at-an-8-8-CAGR-Says-Transparency-Market-Research.html

Stem Cells Market -https://www.globenewswire.com/news-release/2023/04/07/2643266/0/en/Stem-Cells-Market-is-Expected-to-See-a-Growth-of-10-4-from-2021-2028-Reaching-US-25-68-Billion-TMR-Study.html

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.